Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. AKTS
AKTS logo

AKTS Technical

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Technical Sentiment

Overall Consensus

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
12
Buy
5

Technical Analysis Consensus

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
5

Moving Average Consensus

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
0
Aktis Oncology Inc (AKTS) Moving Averages Convergence Divergence (MACD) indicator is 0.14, suggesting AKTS is Strong Sell.
Aktis Oncology Inc (AKTS) 20-Day simple moving average is 19.514, while Aktis Oncology Inc (AKTS) share price is $18.6, making it Sell.
Aktis Oncology Inc (AKTS) 60-Day simple moving average is 18.79, while Aktis Oncology Inc (AKTS) share price is $18.6, making it Sell.

Technical Analysis for AKTS

Technical Sentiment Analysis for Aktis Oncology Inc (AKTS) As of 2026-05-08, Aktis Oncology Inc (AKTS) is exhibiting a Strong Sell technical sentiment. Our proprietary analysis, which aggregates 17 technical signals, shows that 5 indicators are flashing buy, while 12 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for AKTS stands at 46.893, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at 0.14, providing a Buy signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 23.66 and the Commodity Channel Index (CCI) at -49.648 further confirm a -2.66 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, AKTS is trading below its 60-day moving average of $18.79 and below its 200-day long-term moving average of $19.237. Key price levels to watch include the immediate resistance at $21.716 and strong support at $17.266. A break above $21.716 could signal a bull continuation, while falling below $17.266 may test the next Fibonacci floor at $15.383.

Aktis Oncology Inc (AKTS) Support & Resistance Level

NameS3S2S1Pivot PointsR1R2R3
Classic12.81615.38317.26619.83321.71624.28326.166
Fibonacci15.38317.08318.13319.83321.53322.58324.283

Aktis Oncology Inc (AKTS) Technical Indicators

2026-05-08

NameValue
RSI_1446.893
STOCHk_14_3_323.66
STOCHd_14_3_328.289
CCI_20-49.648
AO_5_340.826
MOM_10-2.66
MACD_12_26_9 0.14
Aktis Oncology Inc (AKTS) Relative Strength Index (RSI) is 46.893, creating a Neutral signal.
Aktis Oncology Inc (AKTS) Stochastic Oscillator is 23.66, creating a Neutral signal.
Aktis Oncology Inc (AKTS) Stochastic RSI is 28.289, creating a Neutral signal.
Aktis Oncology Inc (AKTS) Commodity Channel Index (CCI) is -49.648, creating a Neutral signal.
Aktis Oncology Inc (AKTS) Awesome Oscillator is 0.826, creating a Buy signal.
Aktis Oncology Inc (AKTS) Momentum is -2.66, creating a Sell signal.
Aktis Oncology Inc (AKTS) MACD is 0.14, creating a Buy signal.

Aktis Oncology Inc (AKTS) Moving Average

2026-05-08

PeriodSimpleSignal
MA_519.182Sell
MA_1019.149Sell
MA_2019.514Sell
MA_6018.79Sell
MA_20019.237Sell
MA_25019.237Sell
Aktis Oncology Inc (AKTS) 5-Day simple moving average is 19.182, while Aktis Oncology Inc (AKTS) share price is $18.6, making it a Sell.
Aktis Oncology Inc (AKTS) 10-Day simple moving average is 19.149, while Aktis Oncology Inc (AKTS) share price is $18.6, making it a Sell.
Aktis Oncology Inc (AKTS) 20-Day simple moving average is 19.514, while Aktis Oncology Inc (AKTS) share price is $18.6, making it a Sell.
Aktis Oncology Inc (AKTS) 60-Day simple moving average is 18.79, while Aktis Oncology Inc (AKTS) share price is $18.6, making it a Sell.
Aktis Oncology Inc (AKTS) 200-Day simple moving average is 19.237, while Aktis Oncology Inc (AKTS) share price is $18.6, making it a Sell.
Aktis Oncology Inc (AKTS) 250-Day simple moving average is 19.237, while Aktis Oncology Inc (AKTS) share price is $18.6, making it a Sell.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for AKTS?

The overall technical consensus for Aktis Oncology Inc (AKTS) is currently Strong Sell. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 5 buy signals and 6 sell signals.

What are the key support and resistance levels for Aktis Oncology Inc (AKTS) today?

Based on pivot point calculations, Aktis Oncology Inc (AKTS) has an immediate support level at 17.266 and a major resistance level at 21.716. Traders also monitor the pivot point at 19.833 to determine the intraday trend direction.

Is Aktis Oncology Inc (AKTS) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for Aktis Oncology Inc (AKTS) is currently 46.893. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for Aktis Oncology Inc (AKTS)?

Aktis Oncology Inc (AKTS) Moving Averages Convergence Divergence (MACD) indicator is 0.14, suggesting AKTS is Strong Sell. This indicator helps identify potential trend reversals or momentum shifts for Aktis Oncology Inc.

How is Aktis Oncology Inc (AKTS) performing relative to its 200-day moving average?

Aktis Oncology Inc (AKTS) is currently trading at $18.6, which is below its 200-day simple moving average of 19.237. Trading below the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.